NCT04187443View on ClinicalTrials.gov

MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema

PHASE1RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 2, 2020

Primary Completion Date

October 30, 2026

Study Completion Date

December 30, 2026

Conditions
Diabetic Macular EdemaMacular EdemaType 2 Diabetes With Diabetic Macular EdemaType 1 Diabetes With Diabetic Macular EdemaDiabetic Retinopathy
Interventions
DRUG

MS-553

MS-553

Trial Locations (3)

200080

RECRUITING

Shanghai General Hospital, Shanghai

Unknown

RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

RECRUITING

West China Hospital of Sichuan University, Chengdu

Sponsors
All Listed Sponsors
collaborator

Fountain Medical Development Co., Ltd.

INDUSTRY

lead

Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.

INDUSTRY